sTfR/log Ferritin Ratio for Distinguishing Iron Deficiency from Anemia of Chronic Disease
Yes, the sTfR/log ferritin ratio provides superior discrimination compared to either test alone, particularly in patients with chronic inflammatory disease. This is explicitly stated in the most recent British Society of Gastroenterology guidelines from 2021 1.
Evidence from Guidelines
The 2021 BSG guidelines directly address this question, stating that "The [sTfR/log₁₀ ferritin] ratio may provide superior discrimination to either test on its own, particularly in chronic disease" 1. This represents the highest quality guideline evidence available and should guide clinical practice.
The 2013 European consensus on ulcerative colitis management supports this, noting that sTfR determination "can help to make a correct diagnosis" when distinguishing between iron deficiency anemia and anemia of chronic disease in inflammatory bowel disease 2. The guidelines emphasize that sTfR is high in iron deficiency but normal or low in anemia of chronic disease 2.
The earlier 2000 BSG guidelines also recognized this utility, stating that "New tests which involve measuring the serum transferrin binding receptor/ferritin ratio show promise in distinguishing between anaemia of chronic disease and iron deficiency" 3.
Why the Ratio Performs Better
The key advantage is that the ratio compensates for ferritin's limitation as an acute phase reactant. In chronic inflammatory conditions, ferritin levels become artificially elevated due to inflammation, masking true iron deficiency. This creates the diagnostic dilemma where ferritin may appear normal (30-100 μg/L) despite actual iron depletion 2.
The sTfR/log ferritin index addresses this by:
- sTfR increases with iron deficiency regardless of inflammation status
- The logarithmic transformation of ferritin normalizes the distribution
- The ratio calculation amplifies the discriminatory power between the two conditions
Research Evidence Supporting Superior Performance
Multiple studies confirm the superior diagnostic accuracy of the ratio:
A 2019 pediatric IBD study found the sTfR/log ferritin index had diagnostic power (AUC 0.864) superior to sTfR alone (AUC 0.768) for iron deficiency anemia recognition 4
A 2011 IBD case-control study demonstrated that high sTfR-F index (>1.4) had sensitivity 91% and specificity 92% for diagnosing IDA, compared to sTfR alone (>1.8 mg/L) with sensitivity 81% and specificity 80% 5
A 2005 rheumatoid arthritis study showed the ratio had higher discriminating power than sTfR alone in both diagnosing IDA and differentiating it from anemia of chronic disease 6
A 2012 meta-analysis confirmed significant diagnostic utility for both sTfR (odds ratio 22.9) and sTfR index (odds ratio 9.5), though noted the need for additional studies 7
Clinical Application Algorithm
When to use the sTfR/log ferritin ratio:
Ferritin in the "grey zone" (30-100 μg/L) with evidence of inflammation (elevated CRP, ESR)
- This is where the ratio provides maximum clinical value
- Standard ferritin interpretation is unreliable here
Ferritin >100 μg/L with suspected iron deficiency
- If transferrin saturation <16% and clinical suspicion remains high
- The ratio can identify coexisting iron deficiency in anemia of chronic disease
Chronic inflammatory conditions (IBD, rheumatoid arthritis, chronic kidney disease)
Important Caveats
Availability remains limited. The 2021 BSG guidelines note that "most UK hospitals do not provide this test" 1. This practical limitation means many clinicians cannot access this superior diagnostic tool.
sTfR alone has limitations. It can be falsely elevated in conditions with increased erythropoietic drive (hemolytic anemias, thalassemias, hemoglobin E) 1. The ratio partially mitigates this by incorporating ferritin.
Disease-specific thresholds may vary. A 2020 study found that in Crohn's disease specifically, neither ferritin nor transferrin saturation had good diagnostic performance, suggesting sTfR-based testing should be prioritized in this population 8.
Bottom Line
The sTfR/log ferritin ratio is the most accurate non-invasive test for distinguishing iron deficiency anemia from anemia of chronic disease in patients with chronic inflammatory conditions. When available, it should be the preferred diagnostic approach in the ferritin grey zone (30-100 μg/L) or when ferritin interpretation is confounded by inflammation. The ratio consistently outperforms either marker used independently across multiple chronic inflammatory disease populations 1, 4, 5, 6.